In vivo, loss of NEIL1 is better tolerated than loss of TDG. NEIL1 null mice are viable, but develop metabolic syndrome, a combination of severe obesity, dyslipidemia, fatty liver disease, and a tendency for hyperinsulinemia35. Here, NEIL1 is linked to fatty liver disease.